AN-113, a novel prodrug of 4-phenylbutyrate with increased anti-neoplastic activity in glioma cell lines-Reference-Cited by-同舟云学术

AN-113, a novel prodrug of 4-phenylbutyrate with increased anti-neoplastic activity in glioma cell lines

Published:2007-08 Issue:2 Volume:253 Page:205-214
ISSN:0304-3835
Container-title:Cancer Letters
language:en
Short-container-title:Cancer Letters

Author:

Entin-Meer Michal,Rephaeli Ada,Yang Xiaodong,Nudelman Abraham,Nudelman Ayelet,Haas-Kogan Daphne Adele

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference28 articles.

1. Histone modification enzymes: novel targets for cancer drugs;Kristeleit;Expert. Opin. Emerg. Drugs,2004

2. Histone deacetylase inhibitors in cancer treatment;Vigushin;Anticancer Drugs,2002

3. Targeting histone deacetylase in cancer therapy;Lin;Med. Res. Rev.,2006

4. Phenylbutyrate induces apoptosis in human prostate cancer and is more potent than phenylacetate;Carducci;Clin. Cancer Res.,1996

5. Impact of the putative differentiating agents sodium phenylbutyrate and sodium phenylacetate on proliferation, differentiation, and apoptosis of primary neoplastic myeloid cells;Gore;Clin. Cancer Res.,1997

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeting post-translational histone modifying enzymes in glioblastoma;Pharmacology & Therapeutics;2021-04

2. Histone deacetylase inhibitor based prodrugs;European Journal of Medicinal Chemistry;2020-10

3. Species Differences in the Binding of Sodium 4-Phenylbutyrate to Serum Albumin;Journal of Pharmaceutical Sciences;2017-09

4. Acylation or phosphorylation of hydroxyurea unexpectedly takes place on N rather than on O, leading to the formation of amides instead of the expected esters;RSC Advances;2015

5. Delivery of epidrugs;Drug Discovery Today;2014-09